A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
Status:
WITHDRAWN
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Purpose: To decrease symptom burden, improve cognitive function, improve endurance, and decrease fatigue in subjects with post-acute sequelae of COVID-19 (PASC) or "long-hauler" COVID using amantadine. If amantadine use is determined to be efficacious in this population, the findings of this study will be used towards a subsequent randomized control trial.
Phase:
PHASE2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Amantadine Dosage Forms Palliative Care Restraint, Physical Speech Therapy